Taligantinib
Taligantinib (Compound Example 70) is an orally active and selective dual inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2) and hepatocyte growth factor receptor (c-Met) . It effectively suppresses tumor angiogenesis and cell proliferation, and holds potential for the study of solid tumors such as non-small cell lung cancer and hepatocellular carcinoma.
Product Specifications
CAS Number
2243235-80-3
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
O=C (NC1=CC=C (F) C=C1) C2 (C (=O) NC3=CC=C (OC4=CC=NC5=CC (OCCCN6CCOCC6) =C7OCCOC7=C54) C (F) =C3) CC2
Molecular Formula
C35H34F2N4O7
Molecular Weight
660.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A08829-1-Dylight488 100 µg
Anti-MAEL Antibody Picoband® (Dylight488 Conjugate)
Sign In for Pricing
View Details IRBAMSLMAN2AP300120UL 120 µL
Rabbit Anti Mouse LMAN2 Polyclonal Affinity Purified (PBS with 0.02% sodium azide, 50% glycerol, pH7.3) (Immunofluorescence) 120ul
Sign In for Pricing
View Details